Last reviewed · How we verify
FZ-AD004
FZ-AD004 is a Small molecule drug developed by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.. It is currently in Phase 1 development. Also known as: FZ-AD004-Antibody-drug Conjugate.
At a glance
| Generic name | FZ-AD004 |
|---|---|
| Also known as | FZ-AD004-Antibody-drug Conjugate |
| Sponsor | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FZ-AD004 CI brief — competitive landscape report
- FZ-AD004 updates RSS · CI watch RSS
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. portfolio CI
Frequently asked questions about FZ-AD004
What is FZ-AD004?
FZ-AD004 is a Small molecule drug developed by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd..
Who makes FZ-AD004?
FZ-AD004 is developed by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (see full Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. pipeline at /company/shanghai-fudan-zhangjiang-bio-pharmaceutical-co-ltd).
Is FZ-AD004 also known as anything else?
FZ-AD004 is also known as FZ-AD004-Antibody-drug Conjugate.
What development phase is FZ-AD004 in?
FZ-AD004 is in Phase 1.
Related
- Manufacturer: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. — full pipeline
- Also known as: FZ-AD004-Antibody-drug Conjugate
- Compare: FZ-AD004 vs similar drugs
- Pricing: FZ-AD004 cost, discount & access